ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $994,000 | +34.1% | 18,750 | 0.0% | 0.31% | +14.2% |
| Q3 2019 | $741,000 | -3.8% | 18,750 | 0.0% | 0.27% | -11.0% |
| Q2 2019 | $770,000 | -11.8% | 18,750 | 0.0% | 0.30% | -15.0% |
| Q1 2019 | $873,000 | +6.9% | 18,750 | 0.0% | 0.35% | -7.1% |
| Q4 2018 | $817,000 | -23.9% | 18,750 | 0.0% | 0.38% | -39.9% |
| Q3 2018 | $1,073,000 | +17.9% | 18,750 | 0.0% | 0.63% | +60.5% |
| Q2 2018 | $910,000 | +24.1% | 18,750 | 0.0% | 0.40% | +10.3% |
| Q1 2018 | $733,000 | – | 18,750 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |